<DOC>
	<DOCNO>NCT00720421</DOCNO>
	<brief_summary>The purpose study determine effect compound AZD7325 compare lorazepam sleepiness , concentration brain activity .</brief_summary>
	<brief_title>A Sedation/Cognition/Electroencephalogram ( EEG ) Study Using AZD7325 Comparator .</brief_title>
	<detailed_description />
	<mesh_term>Lorazepam</mesh_term>
	<criteria>Healthy male age 18 55 year screen Clinically significant illness within 2 week study start Enrollment another concurrent investigational study intake investigational drug within 30 day intake investigational drug within period 5 half life drug prior screen visit Blood loss excess 200 mL within 30 day Day 2 , excess 400 mL within 90 day Day 2 , excess 1200 mL within 1 year Day 2 Clinically relevant abnormality physical examination , vital sign , ECG , clinical chemistry , hematology urinalysis</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Phase I</keyword>
	<keyword>pharmacodynamic study</keyword>
</DOC>